See more : Mercury Laboratories Limited (MERCURYLAB.BO) Income Statement Analysis – Financial Results
Complete financial analysis of HLS Therapeutics Inc. (HLS.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HLS Therapeutics Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Marksans Pharma Limited (MARKSANS.NS) Income Statement Analysis – Financial Results
- Extraction Oil & Gas, Inc. (XOG) Income Statement Analysis – Financial Results
- CytomX Therapeutics, Inc. (CTMX) Income Statement Analysis – Financial Results
- Nihon Kogyo Co., Ltd. (5279.T) Income Statement Analysis – Financial Results
- Global Petroleum Limited (GBP.L) Income Statement Analysis – Financial Results
HLS Therapeutics Inc. (HLS.TO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.hlstherapeutics.com
About HLS Therapeutics Inc.
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsules; and PERSERIS, an injectable risperidone product for the treatment of schizophrenia. It also offers MyCare psychiatry lab assays and MyCare Insite point of care therapeutic drug-level monitoring tests. In addition, the company holds the U.S. marketing rights of Absorica, a commercial stage dermatology product; Canadian rights of Trinomia for CV therapeutics; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. was founded in 2018 and is headquartered in Etobicoke, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 63.07M | 61.47M | 60.01M | 56.11M | 54.16M | 61.42M | 75.08M | 54.03M | 19.96M | 73.88M | 79.47M | 116.56M | 78.75M | 88.10M | 71.88M | 68.15M | 100.59M | 49.66M | 68.20M | 77.81M | 83.21M | 35.52M | 33.25M | 99.83M | 95.63M | 101.32M | 76.24M | 59.65M |
| Cost of Revenue | 7.62M | 4.98M | 3.97M | 3.63M | 1.93M | 2.60M | 4.14M | -104.16K | -214.75K | 53.03M | 62.51M | 91.43M | 58.24M | 70.45M | 61.21M | 56.65M | 81.86M | 46.45M | 63.88M | 73.18M | 74.11M | 29.89M | 27.52M | 94.67M | 88.86M | 98.39M | 73.65M | 58.24M |
| Gross Profit | 55.45M | 56.49M | 56.04M | 52.48M | 52.23M | 58.82M | 70.95M | 54.14M | 20.17M | 20.85M | 16.96M | 25.13M | 20.51M | 17.65M | 10.67M | 11.50M | 18.73M | 3.21M | 4.32M | 4.63M | 9.10M | 5.62M | 5.73M | 5.16M | 6.77M | 2.92M | 2.59M | 1.41M |
| Gross Profit Ratio | 87.91% | 91.90% | 93.38% | 93.54% | 96.43% | 95.77% | 94.49% | 100.19% | 101.08% | 28.22% | 21.34% | 21.56% | 26.04% | 20.04% | 14.84% | 16.87% | 18.62% | 6.46% | 6.33% | 5.95% | 10.93% | 15.84% | 17.22% | 5.17% | 7.08% | 2.89% | 3.39% | 2.36% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 8.39M | 17.74M | 17.40M | 18.49M | 18.09M | 14.46M | 11.88M | 1.36M | 2.68M | 4.68M | 4.48M | 3.15M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 19.90M | 17.85M | 14.66M | 12.90M | 6.26M | 4.32M | 3.55M | 3.20M | 2.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 28.29M | 35.58M | 32.06M | 31.39M | 24.35M | 18.79M | 15.43M | 1.36M | 2.68M | 4.68M | 4.48M | 3.15M | 3.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.66K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 27.16M | 34.40M | 30.26M | 33.19M | 32.51M | 32.40M | 32.23M | 2.98K | 29.55K | -18.09K | 0.00 | 0.00 | 281.10K | 12.44M | 6.61M | 110.11K | -114.11K | 1.04M | 10.70M | 3.66M | 3.86M | 2.13M | 2.23M | 2.57M | 2.83M | 1.56M | 628.93K | 370.97K |
| Operating Expenses | 55.45M | 69.98M | 62.32M | 64.57M | 56.86M | 51.18M | 47.66M | 1.36M | 2.68M | 4.68M | 4.48M | 3.15M | 4.13M | 12.44M | 6.61M | 4.22M | 6.73M | 1.82M | 2.48M | 3.66M | 3.86M | 2.13M | 2.23M | 2.57M | 2.83M | 1.56M | 628.93K | 370.97K |
| Cost & Expenses | 63.07M | 74.96M | 66.29M | 68.20M | 58.79M | 53.78M | 51.80M | 1.26M | 2.47M | 57.71M | 66.99M | 94.57M | 62.37M | 82.89M | 67.82M | 60.86M | 88.60M | 48.27M | 66.36M | 76.84M | 77.98M | 32.02M | 29.75M | 97.24M | 91.69M | 99.95M | 74.28M | 58.61M |
| Interest Income | 350.00K | 57.00K | 44.00K | 322.00K | 585.00K | 356.00K | 143.00K | 213.53K | 219.07K | 435.88K | 215.07K | 113.59K | 86.19K | 999.55 | -0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 8.75M | 7.32M | 6.96M | 6.31M | 7.70M | 17.11M | 23.36M | 213.53K | 219.07K | 435.88K | 9.39K | 13.07K | 40.16K | 293.95K | 776.43K | 673.79K | 428.00K | 0.00 | 408.00K | 688.00K | 736.00K | 42.45K | 552.19K | 801.44K | 0.00 | 1.20M | 0.00 | 200.00K |
| Depreciation & Amortization | 31.94M | 34.40M | 30.26M | 33.19M | 32.51M | 32.40M | 32.23M | 26.72M | 0.00 | 3.85M | 5.99M | 7.10M | 5.83M | 6.32M | 6.95M | 4.22M | 6.73M | 1.82M | 2.46M | 3.66M | 3.86M | 2.13M | 2.23M | 2.57M | 2.83M | 1.56M | 628.93K | 370.97K |
| EBITDA | 12.88M | 18.00M | 25.41M | 23.19M | 19.75M | 20.70M | 55.52M | 38.24M | -2.47M | 20.01M | 18.46M | 29.19M | 22.29M | 14.10M | 11.01M | 8.66M | 18.73M | 3.21M | 4.30M | 4.63M | 9.10M | 5.62M | 5.73M | 5.16M | 6.77M | 2.92M | 2.52M | 1.41M |
| EBITDA Ratio | 20.43% | 34.10% | 40.03% | 39.08% | 52.56% | 34.91% | 74.13% | -2.32% | -12.36% | 26.54% | 23.51% | 25.05% | 28.31% | 13.09% | 15.31% | 12.71% | 18.54% | 6.54% | 9.21% | 5.95% | 10.93% | 15.84% | 17.22% | 5.17% | 7.08% | 2.89% | 3.39% | 2.36% |
| Operating Income | -10.35M | -13.44M | -6.24M | -11.26M | -4.04M | 7.64M | 23.29M | -1.26M | -2.47M | 16.17M | 12.48M | 21.98M | 16.46M | 17.65M | 4.06M | 4.45M | 12.07M | 1.35M | -143.79K | 969.11K | 5.23M | 3.50M | 3.50M | 2.59M | 3.94M | 1.36M | 1.96M | 1.04M |
| Operating Income Ratio | -16.41% | -21.87% | -10.40% | -20.06% | -7.46% | 12.44% | 31.01% | -2.32% | -12.36% | 21.88% | 15.70% | 18.86% | 20.90% | 20.04% | 5.65% | 6.53% | 12.00% | 2.72% | -0.21% | 1.25% | 6.29% | 9.84% | 10.52% | 2.60% | 4.12% | 1.35% | 2.57% | 1.74% |
| Total Other Income/Expenses | -17.45M | -10.23M | -5.52M | -4.21M | -15.84M | -36.44M | -24.43M | -27.94M | -2.53M | 825.25K | 346.55K | 591.06K | -40.16K | -10.54M | -776.43K | -8.41M | -1.14M | 396.36K | 10.35M | -10.31M | -542.12K | 795.58K | 787.48K | -42.18K | 52.99K | -7.15M | 768.69K | -222.59K |
| Income Before Tax | -27.80M | -23.72M | -11.81M | -16.30M | -20.46M | -28.80M | -1.15M | -1.04M | -2.22M | 16.99M | 12.82M | 22.57M | 16.42M | 1.67M | 3.28M | -3.96M | 10.93M | 1.75M | 10.21M | -8.53M | 4.69M | 4.29M | 4.29M | 2.55M | 5.66M | -5.85M | 2.66M | 816.14K |
| Income Before Tax Ratio | -44.08% | -38.59% | -19.68% | -29.05% | -37.78% | -46.90% | -1.52% | -1.92% | -11.11% | 23.00% | 16.14% | 19.37% | 20.85% | 1.89% | 4.57% | -5.81% | 10.87% | 3.52% | 14.97% | -10.96% | 5.64% | 12.08% | 12.89% | 2.55% | 5.92% | -5.77% | 3.48% | 1.37% |
| Income Tax Expense | -272.00K | -124.00K | 1.31M | -968.00K | -911.00K | -4.00M | 4.95M | -164.42K | -484.98K | 4.27M | 3.09M | 5.71M | 4.09M | 2.40M | 728.68K | 1.68M | 3.34M | 436.68K | 700.88K | 157.22K | 1.80M | 1.34M | 1.38M | 1.15M | 1.10M | 779.88K | 908.46K | -445.17K |
| Net Income | -27.53M | -23.60M | -13.12M | -15.33M | -19.55M | -24.81M | -6.10M | -874.93K | -1.73M | 12.72M | 9.73M | 16.87M | 11.98M | -733.88K | 2.55M | -5.64M | 7.59M | 1.31M | 9.51M | -8.69M | 2.89M | 2.95M | 2.91M | 2.29M | 4.07M | -6.63M | 1.75M | 6.90M |
| Net Income Ratio | -43.65% | -38.39% | -21.86% | -27.32% | -36.10% | -40.39% | -8.12% | -1.62% | -8.68% | 17.21% | 12.25% | 14.47% | 15.22% | -0.83% | 3.55% | -8.28% | 7.55% | 2.64% | 13.94% | -11.17% | 3.47% | 8.30% | 8.75% | 2.29% | 4.26% | -6.54% | 2.29% | 11.57% |
| EPS | -0.85 | -0.73 | -0.41 | -0.48 | -0.67 | -0.92 | -0.24 | -0.04 | -0.10 | 0.65 | 0.49 | 0.83 | 0.60 | -0.03 | 0.11 | -0.22 | 0.33 | 0.06 | 0.46 | -0.46 | 0.15 | 0.13 | 0.18 | 0.21 | 0.39 | -0.69 | 0.23 | 1.03 |
| EPS Diluted | -0.85 | -0.73 | -0.41 | -0.48 | -0.67 | -0.92 | -0.24 | -0.04 | -0.10 | 0.65 | 0.49 | 0.82 | 0.60 | -0.03 | 0.11 | -0.22 | 0.33 | 0.06 | 0.46 | -0.46 | 0.15 | 0.13 | 0.18 | 0.21 | 0.37 | -0.69 | 0.23 | 1.03 |
| Weighted Avg Shares Out | 32.26M | 32.33M | 32.18M | 31.71M | 29.18M | 26.95M | 25.28M | 24.78M | 17.69M | 19.38M | 19.83M | 20.21M | 20.00M | 23.04M | 25.41M | 25.62M | 22.61M | 22.05M | 20.61M | 19.05M | 18.94M | 18.83M | 14.88M | 10.61M | 10.01M | 9.62M | 7.58M | 6.69M |
| Weighted Avg Shares Out (Dil) | 32.26M | 32.43M | 32.18M | 31.71M | 29.36M | 26.95M | 25.28M | 24.78M | 17.69M | 19.38M | 19.83M | 20.35M | 20.17M | 23.23M | 25.41M | 25.62M | 22.61M | 22.05M | 20.61M | 19.06M | 19.02M | 18.94M | 15.04M | 10.68M | 10.01M | 9.62M | 7.58M | 6.69M |
Source: https://incomestatements.info
Category: Stock Reports